WuXi Biologics: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''WuXi Biologics''' is a global company that provides comprehensive, integrated and highly customizable services for the discovery, development and manufacturing of biologics. The company is headquartered in [[Wuxi]], [[China]], and has multiple facilities across China, Europe, and North America.  
{{Short description|A comprehensive overview of WuXi Biologics, a leading global open-access biologics technology platform company.}}


== History ==
==Overview==
WuXi Biologics was founded in 2010 as a subsidiary of [[WuXi AppTec]], a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform company. WuXi Biologics has since grown to become a separate entity, listed on the [[Hong Kong Stock Exchange]] in 2017.
[[WuXi Biologics]] is a leading global open-access biologics technology platform company that provides end-to-end solutions to empower organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing. The company is headquartered in [[Wuxi]], [[China]], and has a significant presence in the [[United States]], [[Europe]], and other regions.


== Services ==
==History==
WuXi Biologics offers a range of services that span the entire biologics value chain, including [[biologics discovery]], [[biologics development]], and [[biologics manufacturing]]. The company's integrated service platform is designed to provide clients with a seamless, efficient, and cost-effective solution for bringing biologics from concept to market.
Founded in 2010, WuXi Biologics has rapidly grown to become a key player in the biologics industry. The company was established as a subsidiary of [[WuXi AppTec]], a well-known pharmaceutical, biotechnology, and medical device company. Over the years, WuXi Biologics has expanded its capabilities and facilities, establishing itself as a leader in the biologics contract development and manufacturing organization (CDMO) sector.


=== Discovery ===
==Services==
In the discovery phase, WuXi Biologics provides services such as [[antibody discovery]], [[protein engineering]], and [[cell line development]]. The company utilizes advanced technologies and platforms, including its proprietary [[Open-CHO Cell Line]] platform, to accelerate the discovery process.
WuXi Biologics offers a comprehensive range of services that cover the entire biologics development process. These services include:


=== Development ===
* '''Discovery Services''': WuXi Biologics provides integrated discovery services, including target validation, antibody generation, and lead optimization.
In the development phase, WuXi Biologics offers services such as [[process development]], [[analytical development]], and [[formulation development]]. The company's development services are designed to optimize the production process and ensure the quality, safety, and efficacy of the biologic.
* '''Development Services''': The company offers process development, analytical development, and formulation development services to ensure the successful transition from discovery to clinical trials.
* '''Manufacturing Services''': WuXi Biologics operates state-of-the-art manufacturing facilities that support clinical and commercial production of biologics. The company is known for its single-use bioreactor technology and flexible manufacturing solutions.
* '''Quality Assurance''': Ensuring the highest quality standards, WuXi Biologics provides comprehensive quality assurance and regulatory support to meet global compliance requirements.


=== Manufacturing ===
==Global Presence==
In the manufacturing phase, WuXi Biologics provides services such as [[clinical manufacturing]], [[commercial manufacturing]], and [[fill/finish]]. The company's manufacturing facilities are equipped with state-of-the-art technologies and adhere to stringent [[Good Manufacturing Practices]] (GMP) standards.
WuXi Biologics has established a global network of facilities and offices to support its international clientele. The company operates multiple facilities in China, including its headquarters in Wuxi, as well as sites in [[Shanghai]] and [[Suzhou]]. In addition, WuXi Biologics has expanded its operations to include facilities in [[Ireland]], [[Germany]], and the [[United States]], enhancing its ability to serve clients worldwide.


== Partnerships ==
==Innovation and Technology==
WuXi Biologics has established partnerships with numerous pharmaceutical and biotechnology companies worldwide. These partnerships enable the company to leverage its capabilities and expertise to accelerate the development and commercialization of innovative biologics.
WuXi Biologics is at the forefront of innovation in the biologics industry. The company invests heavily in research and development to advance its technology platforms. Key areas of innovation include:


== See also ==
* '''Single-Use Bioreactors''': WuXi Biologics is a pioneer in the use of single-use bioreactor systems, which offer flexibility and efficiency in biologics manufacturing.
* [[Biopharmaceutical]]
* '''Continuous Bioprocessing''': The company is developing continuous bioprocessing technologies to improve production efficiency and reduce costs.
* '''Advanced Analytical Techniques''': WuXi Biologics employs cutting-edge analytical techniques to ensure the quality and safety of biologics products.
 
==Strategic Partnerships==
WuXi Biologics has formed strategic partnerships with leading pharmaceutical and biotechnology companies to advance the development of innovative biologics. These collaborations enable the company to leverage its expertise and resources to accelerate the development of new therapies.
 
== Gallery ==
<gallery>
File:Logo of WuXi Biologics.png|Logo of WuXi Biologics
File:WuXi Biologics Headquarters.jpg|WuXi Biologics Headquarters
</gallery>
 
==Related pages==
* [[Biologics]]
* [[Biotechnology]]
* [[Pharmaceutical industry]]
* [[Contract development and manufacturing organization]]
* [[Contract development and manufacturing organization]]
* [[Pharmaceutical industry in China]]


== References ==
[[Category:Biotechnology companies]]
<references />
 
[[Category:Biotechnology companies of China]]
[[Category:Pharmaceutical companies of China]]
[[Category:Pharmaceutical companies of China]]
[[Category:Companies listed on the Hong Kong Stock Exchange]]
[[Category:Companies established in 2010]]
[[Category:2010 establishments in China]]
 
{{pharmacology-stub}}

Latest revision as of 16:58, 8 March 2025

A comprehensive overview of WuXi Biologics, a leading global open-access biologics technology platform company.


Overview[edit]

WuXi Biologics is a leading global open-access biologics technology platform company that provides end-to-end solutions to empower organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing. The company is headquartered in Wuxi, China, and has a significant presence in the United States, Europe, and other regions.

History[edit]

Founded in 2010, WuXi Biologics has rapidly grown to become a key player in the biologics industry. The company was established as a subsidiary of WuXi AppTec, a well-known pharmaceutical, biotechnology, and medical device company. Over the years, WuXi Biologics has expanded its capabilities and facilities, establishing itself as a leader in the biologics contract development and manufacturing organization (CDMO) sector.

Services[edit]

WuXi Biologics offers a comprehensive range of services that cover the entire biologics development process. These services include:

  • Discovery Services: WuXi Biologics provides integrated discovery services, including target validation, antibody generation, and lead optimization.
  • Development Services: The company offers process development, analytical development, and formulation development services to ensure the successful transition from discovery to clinical trials.
  • Manufacturing Services: WuXi Biologics operates state-of-the-art manufacturing facilities that support clinical and commercial production of biologics. The company is known for its single-use bioreactor technology and flexible manufacturing solutions.
  • Quality Assurance: Ensuring the highest quality standards, WuXi Biologics provides comprehensive quality assurance and regulatory support to meet global compliance requirements.

Global Presence[edit]

WuXi Biologics has established a global network of facilities and offices to support its international clientele. The company operates multiple facilities in China, including its headquarters in Wuxi, as well as sites in Shanghai and Suzhou. In addition, WuXi Biologics has expanded its operations to include facilities in Ireland, Germany, and the United States, enhancing its ability to serve clients worldwide.

Innovation and Technology[edit]

WuXi Biologics is at the forefront of innovation in the biologics industry. The company invests heavily in research and development to advance its technology platforms. Key areas of innovation include:

  • Single-Use Bioreactors: WuXi Biologics is a pioneer in the use of single-use bioreactor systems, which offer flexibility and efficiency in biologics manufacturing.
  • Continuous Bioprocessing: The company is developing continuous bioprocessing technologies to improve production efficiency and reduce costs.
  • Advanced Analytical Techniques: WuXi Biologics employs cutting-edge analytical techniques to ensure the quality and safety of biologics products.

Strategic Partnerships[edit]

WuXi Biologics has formed strategic partnerships with leading pharmaceutical and biotechnology companies to advance the development of innovative biologics. These collaborations enable the company to leverage its expertise and resources to accelerate the development of new therapies.

Gallery[edit]

Related pages[edit]